BNB$661-0.41%BRENT$93.43-0.37%BTC$74,639-0.43%COPPER$6.52+1.00%DJI$52,759-1.32%DOGE$0.0820-1.30%DXY98.72-0.18%ETH$2,350-0.34%GOLD$4,532+0.35%NDX$29,213-0.72%SILVER$68.82+1.09%SOL$89.35-0.03%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%BNB$661-0.41%BRENT$93.43-0.37%BTC$74,639-0.43%COPPER$6.52+1.00%DJI$52,759-1.32%DOGE$0.0820-1.30%DXY98.72-0.18%ETH$2,350-0.34%GOLD$4,532+0.35%NDX$29,213-0.72%SILVER$68.82+1.09%SOL$89.35-0.03%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%
MoneyMarket365.comReal-time markets + AI-ranked and AI-analyzed financial news
·Confidence 75%

Zhengye Biotechnology Meets Nasdaq Compliance, Shares Decline

Key takeaways

  • Zhengye Biotechnology has regained compliance with Nasdaq's bid price requirements, yet its shares have experienced a decline following the announcement.
#Nasdaq#Zhengye Biotechnology#Compliance

Analysis

Zhengye Biotechnology has regained compliance with Nasdaq's bid price requirements, yet its shares have experienced a decline following the announcement.

0 likes · 0 dislikes

Comments & Replies

with Google or GitHub to join the discussion.

  • No comments yet be the first to share your view.